Journal article
Effect of recombinant cytokines on glycolysis and fructose 2,6-bisphosphate in rheumatoid synovial cells in vitro.
- Abstract:
- Recombinant-derived human interleukin 1 (IL1) alpha and beta and interferon gamma (IFN-gamma) each produced similar increases in rheumatoid synovial cell (RSC) glycolysis, as judged by increased values for glucose uptake, lactate production and cellular fructose 2,6-bisphosphate [Fru(2,6)P2]. Measurement of Fru(2,6)P2 proved to be the most sensitive parameter for an assessment of glycolysis: IL1 alpha, IL1 beta and IFN-gamma all produced a 3-6-fold increase in this metabolite whereas tumour necrosis factor (TNF alpha) was far less effective. Prostaglandin E production was stimulated predominantly by IL1 alpha and IL1 beta rather than by IFN-gamma or TNF alpha. When combinations of cytokines were examined the addition of IFN-gamma with either IL1 alpha, IL1 beta or murine IL1 produced a synergistic increase in cellular Fru(2,6)P2. The three forms of IL1 increased Fru(2,6)P2 via the same pathway, whereas IFN-gamma acted via a different mechanism. The increase in Fru(2,6)P2 in subcultured RSC produced by addition of medium from a primary culture exceeded the maximal effects of any of the single cytokines studied, suggesting the presence of a mixture of cytokines in the primary RSC culture medium.
- Publication status:
- Published
Actions
Authors
- Journal:
- Biochemical journal More from this journal
- Volume:
- 250
- Issue:
- 1
- Pages:
- 111-115
- Publication date:
- 1988-02-01
- EISSN:
-
1470-8728
- ISSN:
-
0264-6021
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:481889
- UUID:
-
uuid:02474ecb-6353-45c2-af83-ab43932f93d3
- Local pid:
-
pubs:481889
- Source identifiers:
-
481889
- Deposit date:
-
2014-08-29
- ARK identifier:
Terms of use
- Copyright date:
- 1988
If you are the owner of this record, you can report an update to it here: Report update to this record